Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension - Archive ouverte HAL Access content directly
Journal Articles Nature Medicine Year : 2019

Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension

(1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (2) , (2) , (3, 4) , (3, 4) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (11) , (12, 13, 14) , (15, 16) , (12, 17) , (1) , (1) , (1) , (1) , (1, 18) , (1, 18)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Maïthé Tauber
Cécile Aubert
  • Function : Author

Abstract

The G-protein-coupled receptor accessory protein MRAP2 is implicated in energy control in rodents, notably via the melanocortin-4 receptor1. Although some MRAP2 mutations have been described in people with obesity1-3, their functional consequences on adiposity remain elusive. Using large-scale sequencing of MRAP2 in 9,418 people, we identified 23 rare heterozygous variants associated with increased obesity risk in both adults and children. Functional assessment of each variant shows that loss-of-function MRAP2 variants are pathogenic for monogenic hyperphagic obesity, hyperglycemia and hypertension. This contrasts with other monogenic forms of obesity characterized by excessive hunger, including melanocortin-4 receptor deficiency, that present with low blood pressure and normal glucose tolerance4. The pleiotropic metabolic effect of loss-of-function mutations in MRAP2 might be due to the failure of different MRAP2-regulated G-protein-coupled receptors in various tissues including pancreatic islets.
Fichier principal
Vignette du fichier
nat-med-Baron-et-al.pdf (947.91 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-02439220 , version 1 (14-01-2020)

Identifiers

Cite

Morgane Baron, Julie Maillet, Marlène Huyvaert, Aurélie Dechaume, Raphael Boutry, et al.. Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension. Nature Medicine, 2019, 25 (11), pp.1733-1738. ⟨10.1038/s41591-019-0622-0⟩. ⟨inserm-02439220⟩
144 View
130 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More